 Megan Paul
|
|
| Title(s) | RESID PHYS/SUBSPEC/T32/REP, Neurosciences |
|---|
| School | Vc-health Sciences-schools |
|---|
| Address | 9500 Gilman Drive #
La Jolla CA 92093
|
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Overview and recent advances in the targeting of medulloblastoma cancer stem cells. Expert Rev Anticancer Ther. 2021 May 28.
Paul MR, Zage PE. PMID: 34047251.
View in: PubMed Mentions: Fields:
-
Clinical and Neuroimaging Features of Magnetic Resonance-Guided Stereotactic Laser Ablation for Newly Diagnosed and Recurrent Pediatric Brain Tumors: A Single Institutional Series. World Neurosurg. 2021 Mar 12.
Pehlivan KC, Khanna PC, Elster JD, Paul MR, Levy ML, Crawford JR, Gonda DD. PMID: 33722713.
View in: PubMed Mentions: Fields:
-
Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience. J Pediatr Hematol Oncol. 2020 11; 42(8):e730-e737.
Paul MR, Pehlivan KC, Milburn M, Yeh-Nayre L, Elster J, Crawford JR. PMID: 32398601.
View in: PubMed Mentions: 1 Fields:
-
Characterization of G-CSF receptor expression in medulloblastoma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa062.
Paul MR, Huo Y, Liu A, Lesperance J, Garancher A, Wechsler-Reya RJ, Zage PE. PMID: 32642714.
View in: PubMed Mentions:
-
Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance. J Pediatr Hematol Oncol. 2019 Nov; 41(8):e546-e549.
Paul MR, Wong V, Aristizabal P, Kuo DJ. PMID: 30807395.
View in: PubMed Mentions: 2 Fields: Translation: Humans
-
The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo. Oncotarget. 2019 Oct 29; 10(59):6323-6333.
Flynn SM, Lesperance J, Macias A, Phanhthilath N, Paul MR, Kim JW, Tamayo P, Zage PE. PMID: 31695841.
View in: PubMed Mentions: 2 Fields:
-
Deep Vein Thrombosis in a Young, Healthy Baseball Catcher: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 05; 41(4):321-323.
Abood KK, Paul MR, Kuo DJ. PMID: 29401105.
View in: PubMed Mentions: Fields: Translation: Humans
-
Hematologic Manifestations of Nutritional Deficiencies: Early Recognition is Essential to Prevent Serious Complications. J Pediatr Hematol Oncol. 2019 Apr; 41(3):e182-e185.
Yu JC, Shliakhtsitsava K, Wang YM, Paul M, Farnaes L, Wong V, Kim J, Thornburg CD. PMID: 30339653.
View in: PubMed Mentions: Fields: Translation: Humans
-
Severe Neuropathic Pain With Concomitant Administration of Vincristine and Posaconazole. J Pediatr Pharmacol Ther. 2018 Sep-Oct; 23(5):417-420.
Lin MJ, Paul MR, Kuo DJ. PMID: 30429697.
View in: PubMed Mentions:
-
Challenges of assessing response to therapy in non-Hodgkin's lymphoma of the bone. BMJ Case Rep. 2018 Apr 17; 2018.
Paul MR, Kuo DJ. PMID: 29666085.
View in: PubMed Mentions: Fields: Translation: Humans
-
Treatment of immune thrombocytopenic purpura associated with cytomegalovirus infection in a child with pre-B cell acute lymphoblastic leukaemia after central nervous system relapse. BMJ Case Rep. 2017 Sep 25; 2017.
Martinez AR, Paul MR, Kuo DJ. PMID: 28947425.
View in: PubMed Mentions: 1 Fields: Translation: Humans
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2017 | 1 | | 2018 | 2 | | 2019 | 4 | | 2020 | 2 | | 2021 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|